Expansion Therapeutics

Expansion Therapeutics is a biotechnology company focused on developing transformative oral medications for severe RNA-mediated diseases, including neurodegenerative disorders. With global exclusive rights based on groundbreaking research from Dr. Matthew D. Disney's laboratory at Scripps Research, Expansion has assembled intellectual property, proprietary knowledge, and proprietary supporting technologies and tools to facilitate the development of effective and specific small-molecule RNA modulators. Through this unique platform, Expansion is building a pipeline of novel RNA-targeted drug candidates that demonstrate activity in severe RNA-mediated disease indications.